78 Followers on Owler

Assertio

is an Illinois-based specialty pharmaceutical company that develops and commercializes novel therapeutics for the treatment of central nervous system disorders... Read more
OverviewCompetitorsAcquisitionsFundingNews & Insights

Assertio

is an Illinois-based specialty pharmaceutical company that develops and commercializes novel therapeutics for the treatment of central nervous system disorders... Read more
Assertio CEO: Brendan P. O’Grady

CEO

Brendan P. O’Grady

CEO Approval Rating

82/100

1995

PublicIndependent CompanyNASDAQASRT

Pharmaceuticals & Biotechnology
Pharmaceuticals
2834 NAICS listing

Annual Revenue
$125M
Employees
20
Funding
$727.1M
Acquisitions
3

News

Conference Presentation
Mar 20, 2025
Benzinga
Assertio to Participate in the iAccess Alpha Virtual Best Ideas Conference on March 25-26, 2025
Leadership Change
May 29, 2024
GlobalNewswire
Brendan P. O’Grady joined Assertio as CEO

Assertio Competitors

1Neurona
2Oligomerix
3BrainStorm
4AZTherapies
5Cambia Health Solutions
6Arbor
7ZOMIG
8Pfizer
9zembrace
10CO-OP
Unlock 10 + competitors

Trending Companies